Navigation Links
Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy
Date:11/3/2009

th ineffective treatments. Through ongoing personalized diagnosis, we hope to improve patient care and, ultimately, increase survival rates."

Sue Siegel, MDV Partner and On-Q-ity board member, added, "Mara has been at the forefront of personalized medicine and has a proven ability to bring new diagnostics to market. We are excited that the combination of a strong seasoned team and On-Q-ity's arsenal of proprietary technologies can play a key role in our nation's war on cancer and improve patient care while reducing healthcare costs."

In addition to Siegel, Steve Kraus from Bessemer Venture Partners and Dion Madsen from Physic Ventures will join the On-Q-ity board of directors.

About On-Q-ity

On-Q-ity is a next-generation diagnostics company focused on transforming cancer treatment and improving treatment outcomes for cancer patients. The Company is developing innovative diagnostics to identify the unique characteristics of an individual's cancer, predicting the response to therapy, and monitoring the progress of treatment. On-Q-ity was formed earlier this year through the merger of Cellective DX, a developer of microfluidics devices to detect and capture rare circulating tumor cells from the blood of cancer patients, with The DNA Repair Company, a molecular diagnostics company developing biomarker panels to predict response to cancer therapy based on DNA repair pathways in tumors.

The company's CTC and biomarker technologies originated from ground-breaking research at Massachusetts General Hospital and the Dana Farber Cancer Institute and MIT, respectively. The privately-held company, headquartered in Waltham, MA, is funded by Bessemer Venture Partners, MDV-Mohr Davidow Ventures, Physic Ventures and Northgate Capital. For more information, visit: www.On-Q-ity.com.

SOURCE MDV-Mohr Davidow Ventures


'/>"/>
SOURCE MDV-Mohr Davidow Ventures
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ScandiDos Sells 100th Delta4(R) PT Unit as Adoption of Rotational Therapy Cancer Treatment Increases
2. Reportlinker Adds Chinese Markets for Bladder Cancer Treatment Drugs
3. Obesity Significantly Increases Side Effects of Stereotactic Body Radiation Therapy in Lung Cancer Patients
4. superDimension Launches Second Generation iLogic(TM)Electromagnetic Navigation Bronchoscopy System to Detect and Diagnose Lung Cancer
5. Cancer Treatment Guidelines for Diverse Asian Economies Use Model Developed at Fred Hutchinson Cancer Research Center
6. High-Resolution Breast PET Improves Breast Cancer Detection
7. Breast Health is a Year-Round Priority: New Technology Identifies Risk of Breast Cancer in Younger Women
8. Elekta Provides Complete Planning, Treatment and Workflow Solution for Roy and Patricia Disney Family Cancer Center
9. Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer
10. Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer
11. November is Lung Cancer Month: Know the Latest Information About This Deadliest of Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "Investigation Report on ... offering. Developed by Pharmacia & Upjohn ... agonist which effectively reduces intraocular pressure. As the ... (under the trade name of Xalatan) entered ...
(Date:8/28/2015)... -- Perrigo Company plc ("Perrigo") (NYSE: PRGO ; TASE) ... leading OTC brands from GSK in an all cash ... clear demonstration of Perrigo,s unique ability to maximize brand ... 36 countries.  Perrigo Chairman, President and ... excited to complete this transaction, which clearly demonstrates our ...
(Date:8/28/2015)... Massachusetts y LONDRES, 28 de agosto ... AEX: PHIA) anunció hoy su participación en el  ... exhibirá sus soluciones cardiológicas más recientes y novedosas, ... Cardiovascular, que conectan a las personas y la ... de ayudar a diagnosticar, guiar los tratamientos y ...
Breaking Medicine Technology:China Latanoprost Market Investigation Report 2015-2019 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5
... Medical, Inc. (Solta) (Nasdaq: SLTM ), ... today announced that Medicis Technologies Corporation (formerly LipoSonix, ... has received U.S. Food and Drug Administration (FDA) ... indicated for non-invasive waist circumference reduction. The LipoSonix ...
... SPRING, Md., Oct. 24, 2011 The U.S. ... generic versions of Zyprexa (olanzapine tablets) and Zyprexa ... and bipolar disorder. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... and disabling brain disorder. About 1 percent of ...
Cached Medicine Technology:Solta Medical Reports FDA Clearance Received for Second Generation LipoSonix® System 2Solta Medical Reports FDA Clearance Received for Second Generation LipoSonix® System 3Solta Medical Reports FDA Clearance Received for Second Generation LipoSonix® System 4Solta Medical Reports FDA Clearance Received for Second Generation LipoSonix® System 5FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder 2FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder 3
(Date:8/29/2015)... ... August 29, 2015 , ... "I have been a licensed ... "I specialize in manual therapy, and my invention will provide headache sufferers a ... additional muscle dysfunction throughout the body." , They developed THE RELIEVER to alleviates ...
(Date:8/29/2015)... ... ... Next weekend is Labor Day weekend, the last bash of the season ... year). For IT security personnel, it should also mark the perfect time to make ... than a simple headache. , Joe Caruso, founder and CEO-CTO of Global Digital ...
(Date:8/29/2015)... TX (PRWEB) , ... August 29, 2015 , ... ... allows the company to freely market and sell Arterosil and Arterosil HP, and ... Health Sciences, LLC (DHS) sued Vascular Health Sciences, LLC (VHS) in the United ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Kentucky State Department of Workforce Investment ... position they are applying for, they are unable to pass the initial drug test ... drug testing policies in order to be able to hire long-term, skilled talent. (1) ...
(Date:8/28/2015)... ... ... As reported by Medical Daily on August 22 , Cellfina, a non-invasive ... two years, the longest of any cellulite reduction system currently on the market. ... solution for their cellulite, according to Dr. Robert Weiss, director of the premier MD ...
Breaking Medicine News(10 mins):Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3
... said on Friday that more than 300 people reported ill ... Olive Garden restaurant at Indianapolis// last weekend, a day after ... restaurants. ,The restaurant is closed temporarily and health ... ,Leftover food and stool samples were collected ...
... prevalence of obesity could bankrupt the health system, warn doctors ... over half the population is overweight and more than one ... Obese people are at high risk of multiple health problems, ... is currently estimated at up to 9%, and the overall ...
... Supplement, a product containing the drug estazolam, which might make ... months. // ,Estazolam belongs to benzodiazepines class of ... as it may have a number of side effects like ... is not legal to sell it in Canada. ,Hence, ...
... pneumonia in the Downtown Eastside with more than 70 cases ... Downtown Eastside has clearly pushed the health supporting system to ... memo, David Butcher, vice-president of medicine for Northern Health, warned ... limiting the availability of ICU beds. ,"At the ...
... a weekend night over, ice has become an integral part of ... drugs used by people along with ice are marijuana, ketamine, heroin ... mask the effects of these drugs when they have report to ... pleasurable sensation in my head, after which they usually smoke ice ...
... Expression of two different proteins taken from primary tumor ... to nearby lymph nodes, according to researchers who// say ... stage those patients whose disease is likely to metastasize. ... Research, the researchers say over-expression of one unidentified protein ...
Cached Medicine News:Health News:Obesity Could Bankrupt the Health System, Warn Doctors 2Health News:Researchers Find Two Biomarkers With Potential to Predict Breast Cancer Spread 2Health News:Researchers Find Two Biomarkers With Potential to Predict Breast Cancer Spread 3Health News:Researchers Find Two Biomarkers With Potential to Predict Breast Cancer Spread 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: